Publications by authors named "Luke Kwon"

Claim this Profile
C
Correction: Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs.
Kevin Wyszatko, Melissa Chassé, Nancy Janzen, Luis Rafael Silva, Luke Kwon

EJNMMI Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific radioimmunoconjugates exploit receptor heterogeneity for positron emission tomography of tumors expressing HER2 and/or EGFR.
Luke Yongkyu Kwon, Zhongli Cai, Azza Al-Mahrouki, Raymond M Reilly

iScience· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs.
Kevin Wyszatko, Melissa Chassé, Nancy Janzen, Luis Rafael Silva, Luke Kwon

EJNMMI Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cu-Labeled Trastuzumab Fab-PEG-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents.
Luke Yongkyu Kwon, Deborah A Scollard, Raymond M Reilly

Mol Pharm· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis